Yttrium-90 microspheres: radiation therapy for unresectable liver cancer
about
sameAs
Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developmentsYttrium-90 radioembolization of liver tumors: what do the images tell us?Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectivesAgreement between competing imaging measures of response of hepatocellular carcinoma to yttrium-90 radioembolization.Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.Radiation safety issues in y-90 microsphere selective hepatic radioembolization therapy: possible radiation exposure from the patients.Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model.Direct in vivo injection of 131I-GMS and its distribution and excretion in rabbitCoordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of diseaseInitial study of radiological and clinical efficacy radioembolization using 188Re-human serum albumin (HSA) microspheres in patients with progressive, unresectable primary or secondary liver cancers.Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis.Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver.Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlationMulticenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres.Radioembolization for primary and metastatic liver cancer.Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis.Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio.Radioactive holmium acetylacetonate microspheres for interstitial microbrachytherapy: an in vitro and in vivo stability study.Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomesIncreased absorbed liver dose in Selective Internal Radiation Therapy (SIRT) correlates with increased sphere-cluster frequency and absorbed dose inhomogeneityTranscatheter intraarterial therapies: rationale and overviewHepatic imaging response to radioembolization with yttrium-90-labeled resin microspheres for tumor progression during systemic chemotherapy in patients with colorectal liver metastases.SPIO-labeled Yttrium Microspheres for MR Imaging Quantification of Transcatheter Intrahepatic Delivery in a Rodent Model.Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs.Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical reviewRadionuclide carriers for targeting of cancer.Baseline hemoglobin and liver function predict tolerability and overall survival of patients receiving radioembolization for chemotherapy-refractory metastatic colorectal cancerNanovectorized radiotherapy: a new strategy to induce anti-tumor immunity.VIP inhibits human HepG2 cell proliferation in vitro.Current approach in the treatment of hepatocellular carcinoma.Practical reconstruction protocol for quantitative (90)Y bremsstrahlung SPECT/CT.Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases.Utility of Quantitative Tc-MAA SPECT/CT for yttrium-Labelled Microsphere Treatment Planning: Calculating Vascularized Hepatic Volume and Dosimetric Approach.Hepatic intra-arterial infusion of yttrium-90 microspheres in the treatment of recurrent hepatocellular carcinoma after liver transplantation: a case report.Effects of TACE combined with precise RT on p53 gene expression and prognosis of HCC patients
P2860
Q26852174-D8D890FE-30DA-4429-88D6-CEB240E83394Q26997064-889ACD64-E48E-4F88-BE61-24DF0BB3C7A1Q27023616-6FB85341-D594-45AB-93FF-FC3F57182D29Q33532957-1443398D-E790-40F6-9B7D-AC32E862908AQ33691454-7B8B4B87-72B2-48F7-AB1B-38C01168F371Q33704034-29FAA1ED-8B46-4895-9445-218F6A24162AQ33715683-3508C743-7726-4837-B199-39B19D312B38Q33830713-EF1B1502-A0AD-4456-886D-DEE8BD7DC51AQ33870879-12919D71-B1A0-40C0-B024-69CF106B6C8BQ34062165-52B56787-B6BE-4DAE-8F9E-CC68D8E3550BQ34155198-7EA4E0D5-1C5B-4EA0-B55F-C4DB01B1489CQ34563356-9FDE8B38-41E5-445C-A852-5797E7881E7DQ34982068-9867EE66-B0A6-4DE8-9915-70175A7C5F83Q35028984-5825A9D4-9F0B-41DE-91BF-2AAE39F56152Q35564038-72942CFC-603F-4546-A388-FB55A03CA426Q35658025-F3AA4150-275E-4478-9C28-0428BA38064BQ35738820-3D3CBBCB-9925-486B-A695-AFFFD295D61DQ35761648-9824CB34-C66F-4AE0-B0A3-F7843A875A42Q35815482-F5F2FEDA-3825-4414-A852-E1AB5F82E1ECQ35985132-34632DCE-FF5C-4197-A9D6-927723AEF785Q36104314-94ECF9CE-9743-46A9-8C40-974EA41C1462Q36352452-F1002545-723A-4121-9C40-B8CBE4F2C2AFQ36524415-F75A9E65-5805-476B-AA20-B228E4B15BD2Q36738344-8D19E2C1-1324-4096-8197-59B94249E2FCQ37113543-D66A7449-79ED-42DC-9AE0-18DC2B09E26EQ37237705-01ACBB1C-E929-4FF5-8928-6092EFF3F53BQ37677524-915D84C4-9ED5-4BF3-B742-2FC8A935902BQ38054112-113DA3DA-830D-47EE-A3DC-B04725FA0C43Q40036174-60B9132D-CC51-4224-8541-946E600EFE48Q41133765-90AD5755-46FF-4715-A515-54ECEF161BEBQ41511799-1FEDEEC6-8F41-416B-82A8-778908C10A55Q41598539-F80F93CA-BFA1-4FD1-9358-62C259D1E8ADQ42006201-05A3CACF-A63C-4547-98D5-9E989F2F457BQ42015157-55695C6F-FAF6-4BC6-AD70-D3AE17350FA5Q57788780-C6DCD7A8-1060-46AA-A2B7-A182B5909B20
P2860
Yttrium-90 microspheres: radiation therapy for unresectable liver cancer
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Yttrium-90 microspheres: radiation therapy for unresectable liver cancer
@ast
Yttrium-90 microspheres: radiation therapy for unresectable liver cancer
@en
Yttrium-90 microspheres: radiation therapy for unresectable liver cancer
@nl
type
label
Yttrium-90 microspheres: radiation therapy for unresectable liver cancer
@ast
Yttrium-90 microspheres: radiation therapy for unresectable liver cancer
@en
Yttrium-90 microspheres: radiation therapy for unresectable liver cancer
@nl
prefLabel
Yttrium-90 microspheres: radiation therapy for unresectable liver cancer
@ast
Yttrium-90 microspheres: radiation therapy for unresectable liver cancer
@en
Yttrium-90 microspheres: radiation therapy for unresectable liver cancer
@nl
P2093
P1476
Yttrium-90 microspheres: radiation therapy for unresectable liver cancer
@en
P2093
Brian I Carr
James E Goin
Jean-Francois H Geschwind
Kenneth G Thurston
Riad Salem
P304
P407
P433
P577
2002-09-01T00:00:00Z